Top compounds associated with response to VTN


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.2
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.2
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA SR-II-138A CTRPv2 pan-cancer AAC -0.038 0.2
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.2
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC -0.042 0.2
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.2
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.037 0.2
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.056 0.2
Download CSV